We provide you with the second issue of JHPOR. As seen in the table of contents pharmacoeconomics, health policy and results of clinical trials are becoming increasingly important in shaping the health care system in Poland. The development of health technology assessment indicates that more and more work is devoted to the costs and cost-effectiveness of health technologies in Poland. It should be noted how important the comparative analysis of these phenomena with other countries is.
During the latest congress of ISPOR in Berlin we had the honor to participate in the Polish-Russian forum, which focused on common solutions for the reimbursement of medicines and medical devices in both countries. An in-depth analysis of the problem is presented in this issue. One of the articles refers to the role of a new type of health insurance, the so-called complementary health insurance. In our opinion this solution should be implemented into our health care system in the near future. The content of this JHPOR issue shows the enormous space for such publications in Poland. We encourage all stakeholders, especially members of the Polish Society of Pharmacoeconomics to publish in future editions of our Journal.
At the same time we hope you will find current issue interesting.

Editor- in-Chief
Karina Jahnz-Różyk
Deputy Editor- in-Chief
Joanna Lis